Comment to the founders’ sale of shares
The two founders of ODI Pharma AB (“ODI” or “Company”), Derek Simmross and Volker Wiederrich, yesterday sold a part of their respective holdings in the Company. The total sale amounts to 251,166 shares. The founders’ holdings prior to the IPO remains, and the founders have no intention to sell more than what has already been sold.Derek Simmross, CEO, and Volker Wiederrich, Chairman of the Board, comment “We have understood that the share sale we made yesterday has caused some concern. We want to clarify the reasons behind the sale, which are personal financial reasons as we have not, and